Fed. Circ. Urged Not To Stay Immunity Ruling For Appeal
A trio of generic-drug makers have urged the Federal Circuit not to stay its ruling that sovereign immunity doesn't apply in inter partes reviews, arguing that Allergan PLC and the St....To view the full article, register now.
Already a subscriber? Click here to view full article